Trial · NCT00680745
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Adjusted Mean Change in HbA1c Levels | Dapagliflozin 2.5mg + Glimepiride | -0.58 | 95% Confidence Interval -0.69 to -0.46 | Percent | |
| Adjusted Mean Change in HbA1c Levels | Dapagliflozin 5mg + Glimepiride | -0.63 | 95% Confidence Interval -0.75 to -0.50 | Percent | |
| Adjusted Mean Change in HbA1c Levels | Dapagliflozin 10mg + Glimepiride | -0.82 | 95% Confidence Interval -0.94 to -0.70 | Percent | |
| Adjusted Mean Change in HbA1c Levels | Placebo + Glimepiride | -0.13 | 95% Confidence Interval -0.26 to -0.01 | Percent | |
| Adjusted Mean Change in Body Weight | Dapagliflozin 2.5mg + Glimepiride | -1.18 | 95% Confidence Interval -1.62 to -0.75 | kg | |
| Adjusted Mean Change in Body Weight | Dapagliflozin 5mg + Glimepiride | -1.56 | 95% Confidence Interval -2.01 to -1.11 | kg | |
| Adjusted Mean Change in Body Weight | Dapagliflozin 10mg + Glimepiride | -2.26 | 95% Confidence Interval -2.70 to -1.83 | kg | |
| Adjusted Mean Change in Body Weight | Placebo + Glimepiride | -0.72 | 95% Confidence Interval -1.16 to -0.28 | kg | |
| Adjusted Mean Change in 2-h Post-challenge Plasma Glucose Rise | Dapagliflozin 2.5mg + Glimepiride | -37.5 | 95% Confidence Interval -46.7 to -28.3 | mg/dL | |
| Adjusted Mean Change in 2-h Post-challenge Plasma Glucose Rise | Dapagliflozin 5mg + Glimepiride | -32.0 | 95% Confidence Interval -41.5 to -22.5 | mg/dL | |
| Adjusted Mean Change in 2-h Post-challenge Plasma Glucose Rise | Dapagliflozin 10mg + Glimepiride | -34.9 | 95% Confidence Interval -43.8 to -25.9 | mg/dL | |
| Adjusted Mean Change in 2-h Post-challenge Plasma Glucose Rise | Placebo + Glimepiride | -6.0 | 95% Confidence Interval -15.8 to 3.9 | mg/dL | |
| Proportion of Participants Achieving Glycemic Response Defined as HbA1c <7% | Dapagliflozin 2.5mg + Glimepiride | 26.8 | 95% Confidence Interval 20.2 to 33.3 | Percentage of participants | |
| Proportion of Participants Achieving Glycemic Response Defined as HbA1c <7% | Dapagliflozin 5mg + Glimepiride | 30.3 | 95% Confidence Interval 23.4 to 37.1 | Percentage of participants | |
| Proportion of Participants Achieving Glycemic Response Defined as HbA1c <7% | Dapagliflozin 10mg + Glimepiride | 31.7 | 95% Confidence Interval 24.7 to 38.7 | Percentage of participants | |
| Proportion of Participants Achieving Glycemic Response Defined as HbA1c <7% | Placebo + Glimepiride | 13.0 | 95% Confidence Interval 7.6 to 18.4 | Percentage of participants | |
| Adjusted Mean Change in Body Weight for Participants With Baseline Body Mass Index (BMI)≥27 kg/m2 | Dapagliflozin 2.5mg + Glimepiride | -1.17 | 95% Confidence Interval -1.75 to -0.59 | kg | |
| Adjusted Mean Change in Body Weight for Participants With Baseline Body Mass Index (BMI)≥27 kg/m2 | Dapagliflozin 5mg + Glimepiride | -1.74 | 95% Confidence Interval -2.34 to -1.15 | kg | |
| Adjusted Mean Change in Body Weight for Participants With Baseline Body Mass Index (BMI)≥27 kg/m2 | Dapagliflozin 10mg + Glimepiride | -2.47 | 95% Confidence Interval -3.06 to -1.88 | kg | |
| Adjusted Mean Change in Body Weight for Participants With Baseline Body Mass Index (BMI)≥27 kg/m2 | Placebo + Glimepiride | -0.80 | 95% Confidence Interval -1.38 to -0.22 | kg |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00680745/results